NO20091297L - Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet - Google Patents

Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet

Info

Publication number
NO20091297L
NO20091297L NO20091297A NO20091297A NO20091297L NO 20091297 L NO20091297 L NO 20091297L NO 20091297 A NO20091297 A NO 20091297A NO 20091297 A NO20091297 A NO 20091297A NO 20091297 L NO20091297 L NO 20091297L
Authority
NO
Norway
Prior art keywords
compounds
compatibility
low
corticosteroid
pharmacologically active
Prior art date
Application number
NO20091297A
Other languages
English (en)
Inventor
Michael Fox
Rakefet Cohen
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20091297L publication Critical patent/NO20091297L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytiske preparater omfattende minst én vitamin-D-holdig forbindelse, minst én kortikosteroidforbindelse og minst én oppløsningsmiddelkomponent valgt fra gruppen bestående av triglyserider, sorbitan, sorbitanfettsyreestere, cetearylglukosid, PEG-n-sorbitanstearat, akrylamid/natriumakryloyldimetyltaurat-kopolymerer, og blandinger derav. Det beskrives også fremgangsmåter for fremstilling av slike preparater og fremgangsmåter for behandling av psoriasis ved bruk av slike preparater.
NO20091297A 2006-08-29 2009-03-27 Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet NO20091297L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84116406P 2006-08-29 2006-08-29
PCT/US2007/019164 WO2008027532A2 (en) 2006-08-29 2007-08-29 Pharmaceutical compositions including vitamin d and corticosteroid

Publications (1)

Publication Number Publication Date
NO20091297L true NO20091297L (no) 2009-03-27

Family

ID=38880988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091297A NO20091297L (no) 2006-08-29 2009-03-27 Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet

Country Status (12)

Country Link
US (3) US20080064669A1 (no)
EP (1) EP2056791A2 (no)
JP (1) JP2010502624A (no)
KR (2) KR20110113664A (no)
CN (1) CN101505725A (no)
BR (1) BRPI0715636A2 (no)
CA (1) CA2670425A1 (no)
IL (1) IL197107A0 (no)
MX (1) MX2009002337A (no)
NO (1) NO20091297L (no)
RU (1) RU2452488C2 (no)
WO (1) WO2008027532A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20060176966A1 (en) * 2005-02-07 2006-08-10 Stewart Kenneth A Variable cyclic prefix in mixed-mode wireless communication systems
CA2761039A1 (en) * 2009-05-07 2010-11-11 Tolmar, Inc. Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
US20110053898A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Topical composition comprising vitamin d analogue and corticosteroids
US8518917B2 (en) * 2009-10-02 2013-08-27 Wisconsin Alumni Research Foundation 2-methylene-19-nor-vitamin D analogs and their uses
JP5712010B2 (ja) * 2010-03-24 2015-05-07 第一三共ヘルスケア株式会社 ビタミンｄ類が安定化された化粧用又は医薬用外用組成物
WO2012127037A2 (en) * 2011-03-24 2012-09-27 Leo Pharma A/S A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
CA2834301A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Treatment of psoriasis
CN103946218B (zh) * 2011-07-29 2016-03-09 北京贝美拓新药研发有限公司 抑制脯氨酸羟化酶活性的化合物的稳定晶型及其应用
US20170072321A1 (en) * 2013-05-22 2017-03-16 David S. Thompson Highly interactive fantasy sports interleaver
WO2017118885A1 (en) * 2016-01-04 2017-07-13 Gland Pharma Limited Stable pharmacuetical compositions of calcitriol
EP3542788A1 (en) * 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
CN108815174A (zh) * 2018-05-25 2018-11-16 昆山普瑞凯纳米技术有限公司 一种改良型脂溶性组合物及其制备方法
US20210196631A1 (en) * 2018-08-28 2021-07-01 Glenmark Pharmaceuticals Limited Container system and pharmaceutical foam composition comprising betamethasone

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US4594340A (en) * 1984-11-29 1986-06-10 Hoffmann-La Roche Inc. 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture
AU603340B2 (en) * 1985-08-02 1990-11-15 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
US5824313A (en) * 1989-09-25 1998-10-20 University Of Utah Research Foundation Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5789397A (en) * 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
US5763426A (en) * 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US6372731B1 (en) * 1995-06-14 2002-04-16 Schering Aktiengesellschaft Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
JPH11514999A (ja) * 1995-10-10 1999-12-21 ストルーブ，マリリン ビタミンｄおよびその誘導体による掻痒症治療
AU5347696A (en) * 1995-11-20 1997-06-11 Kiyoshi Kita External preparation containing vitamin d or vitamin k
GB9524812D0 (en) * 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
TWI247001B (en) * 1996-07-01 2006-01-11 Chugai Pharmaceutical Co Ltd The method for purifying vitamin d derivatives and its crystalline products
GB9622590D0 (en) * 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
EP0981514B1 (en) * 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6599513B2 (en) * 1997-05-27 2003-07-29 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6187331B1 (en) * 1997-06-10 2001-02-13 New Vision Co., Ltd. Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D
GB9721156D0 (en) * 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
JP2002508383A (ja) * 1997-12-17 2002-03-19 シエーリング アクチエンゲゼルシャフト 側鎖中にリン原子を有するビタミンｄ誘導体
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
JP2000064450A (ja) * 1998-08-21 2000-02-29 Kikkona Kk 断熱性に優れたパネル材および断熱性に優れたパネル構造体
SK287653B6 (sk) * 1999-04-23 2011-05-06 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Nevodná farmaceutická kompozícia na dermálne použitie
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
CA2423930C (en) * 2000-10-27 2009-11-24 Leo Pharma A/S Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
WO2003087048A2 (en) * 2002-04-11 2003-10-23 Instytut Farmaceutyczny Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds
US9221753B2 (en) * 2004-02-03 2015-12-29 Chugai Seiyaku Kabushiki Kaisha Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
DE602005003138T3 (de) * 2004-06-17 2011-07-14 Galderma S.A. Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
CA2567683A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene

Also Published As

Publication number Publication date
KR20110113664A (ko) 2011-10-17
MX2009002337A (es) 2009-03-20
EP2056791A2 (en) 2009-05-13
RU2009109164A (ru) 2010-10-10
IL197107A0 (en) 2009-11-18
JP2010502624A (ja) 2010-01-28
RU2452488C2 (ru) 2012-06-10
KR20090039833A (ko) 2009-04-22
WO2008027532A3 (en) 2008-04-17
CA2670425A1 (en) 2008-03-06
CN101505725A (zh) 2009-08-12
BRPI0715636A2 (pt) 2013-07-02
US20120028934A1 (en) 2012-02-02
WO2008027532A2 (en) 2008-03-06
US20120046253A1 (en) 2012-02-23
US20080064669A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
NO20091297L (no) Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
WO2010093727A8 (en) Quinazolinones as prolyl hydroxylase inhibitors
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
BRPI0517792A (pt) macrolonas - quinolonas amino-substituìdas
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
WO2008061226A3 (en) Sustained-release formulations of topiramate
AR047993A1 (es) Composicion farmaceutica que comprende pimobendano
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
AR047928A1 (es) Derivados de tetrahidropiridoindol
UA95199C2 (en) Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
NO20082730L (no) Morfolinopyrimidinderivater og deres anvendelse i terapi
NO20080408L (no) Azaindazolforbindelser og anvendelse derav
PL1940249T3 (pl) Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności
WO2007135527A3 (en) Benzimidazolyl compounds
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
EA201000436A1 (ru) Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью
WO2006083780A3 (en) Glucuronidated nebivolol
EP2142549A4 (en) ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
WO2005105768A3 (en) Process for preparation of mycophenolic acid and ester derivatives thereof
PA8566601A1 (es) Derivados de nicotinamida utiles como inhibidores de pde4
WO2008012338A3 (en) Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application